| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Breast Imaging |
1 Department of Diagnostic Imaging, Istituto Policlinico San Donato, Via Morandi
30, San Donato Milanese, Milan 20097, Italy.
2 Institute of Radiology, University of Ancona, Via Conca, Ancona 60020,
Italy.
3 Department of Radiology, Vita-Salute University, San Raffaele Hospital, Via
Olgettina 60, Milan 20132, Italy.
4 Institute of Radiology, Udine University, Via Colugna 50, Udine 33100,
Italy.
5 Department of Diagnostic Imaging and Interventional Radiology, University of
Tor Vergata, Viale Oxford 81, Rome 00133, Italy.
6 Department of Senology, Policlinico Universitario, Piazza G. Cesare 11, Bari
70124, Italy.
OBJECTIVE. Our aim was to compare the effectiveness of mammography and MRI in the detection of multifocal, multicentric breast cancer.
SUBJECTS AND METHODS. Ninety patients with planned mastectomies (nine bilateral) underwent mammography and dynamic gadolinium-enhanced MRI. Off-site reviewers aware of the entry criterion (planned mastectomy) evaluated both examinations for the presence of malignant foci, recording the density pattern on mammography. The gold standard was pathologic examination of the whole excised breast (slice thickness, 5 mm).
RESULTS. Of 99 breasts, pathologic findings revealed 52 unifocal, 29 multifocal, and 18 multicentric cancers for a total of 188 malignant foci (158 invasive and 30 in situ). Overall sensitivity was 66% (124/188) for mammography and 81% (152/188) for MRI (p < 0.001); 72% (113/158) and 89% (140/158) for invasive foci (p < 0.001); and 37% (11/30) and 40% (12/30) for in situ foci (p > 0.05, not significant), respectively. Mammography and MRI missed 64 and 36 malignant foci, respectively, with median diameters of 8 and 5 mm (p = 0.033) and an invasive–noninvasive ratio of 2.4:1 (45:19) and 1.0:1 (18:18) (p = 0.043), respectively. The overall positive predictive value (PPV) was 76% (124/164) for mammography and 68% (152/222) for MRI (not significant). In breasts with an almost entirely fatty pattern, sensitivity was 75% for mammography and 80% for MRI (not significant), and the PPV was 73% and 65% (not significant), respectively. In breasts with fibroglandular or dense pattern, the sensitivity was 60% and 81% (p < 0.001), and the PPV was 78% and 71% (not significant), respectively.
CONCLUSION. MRI was more sensitive than mammography for the detection of multiple malignant foci in fibroglandular or dense breasts. Mammography missed larger and more invasive cancer foci than MRI. A relatively low PPV was a problem for both techniques.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Romano Radiology in Italy: What Is Happening? Am. J. Roentgenol., October 1, 2009; 193(4): W273 - W277. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Houssami and D. F. Hayes Review of Preoperative Magnetic Resonance Imaging (MRI) in Breast Cancer: Should MRI Be Performed on All Women with Newly Diagnosed, Early Stage Breast Cancer? CA Cancer J Clin, September 1, 2009; 59(5): 290 - 302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Houssami Overview of the Evidence on MRI-guided Local Staging of Breast Cancer and Effect on Treatment ASCO Educational Book, January 1, 2009; 2009(1): 45 - 50. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pediconi, C. Catalano, S. Padula, A. Roselli, V. Dominelli, S. Cagioli, M. A. Kirchin, G. Pirovano, and R. Passariello Contrast-Enhanced MR Mammography: Improved Lesion Detection and Differentiation with Gadobenate Dimeglumine Am. J. Roentgenol., November 1, 2008; 191(5): 1339 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Houssami, S. Ciatto, P. Macaskill, S. J. Lord, R. M. Warren, J. M. Dixon, and L. Irwig Accuracy and Surgical Impact of Magnetic Resonance Imaging in Breast Cancer Staging: Systematic Review and Meta-Analysis in Detection of Multifocal and Multicentric Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3248 - 3258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Morrow Magnetic Resonance Imaging in the Breast Cancer Patient: Curb Your Enthusiasm J. Clin. Oncol., January 20, 2008; 26(3): 352 - 353. [Full Text] [PDF]
|
|
|
|
|
|
L. J. Solin, S. G. Orel, W.-T. Hwang, E. E. Harris, and M. D. Schnall Relationship of Breast Magnetic Resonance Imaging to Outcome After Breast-Conservation Treatment With Radiation for Women With Early-Stage Invasive Breast Carcinoma or Ductal Carcinoma in Situ J. Clin. Oncol., January 20, 2008; 26(3): 386 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. H. G. M. Peters, I. H. M. Borel Rinkes, N. P. A. Zuithoff, W. P. T. M. Mali, K. G. M. Moons, and P. H. M. Peeters Meta-Analysis of MR Imaging in the Diagnosis of Breast Lesions Radiology, December 1, 2007; 246(1): 116 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. Kuhl Current Status of Breast MR Imaging * Part 2. Clinical Applications Radiology, September 1, 2007; 244(3): 672 - 691. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Williams, W. B. DeMartini, S. C. Partridge, S. Peacock, and C. D. Lehman Breast MR Imaging: Computer-aided Evaluation Program for Discriminating Benign from Malignant Lesions Radiology, July 1, 2007; 244(1): 94 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pediconi, C. Catalano, A. Roselli, S. Padula, F. Altomari, E. Moriconi, A. M. Pronio, M. A. Kirchin, and R. Passariello Contrast-enhanced MR Mammography for Evaluation of the Contralateral Breast in Patients with Diagnosed Unilateral Breast Cancer or High-Risk Lesions Radiology, June 1, 2007; 243(3): 670 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Saslow, C. Boetes, W. Burke, S. Harms, M. O. Leach, C. D. Lehman, E. Morris, E. Pisano, M. Schnall, S. Sener, et al. American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography CA Cancer J Clin, March 1, 2007; 57(2): 75 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Oh, M. J. Dryden, W. A. Woodward, T.-K. Yu, W. Tereffe, E. A. Strom, G. H. Perkins, L. Middleton, K. K. Hunt, S. H. Giordano, et al. Locoregional Control of Clinically Diagnosed Multifocal or Multicentric Breast Cancer After Neoadjuvant Chemotherapy and Locoregional Therapy J. Clin. Oncol., November 1, 2006; 24(31): 4971 - 4975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Schillaci Is There a Clinical Role for Scintimammography in Breast Cancer Diagnosis? J. Nucl. Med., October 1, 2005; 46(10): 1571 - 1573. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
